Misfolded α-synuclein aggregates are transmitted via exosomes from donor to recipient neurons, templating endogenous aSyn misfolding through a 'prion-like' mechanism that explains Braak staging progression patterns. This hypothesis is biologically plausible but causally unproven—the exosome field struggles to distinguish propagation vectors from secondary clearance mechanisms. Druggability is severely constrained by the essential physiological functions of exosomes (synaptic function, immune surveillance, waste removal). The essential-function problem makes therapeutic inhibition appear inherently risky. However, GBA modulation (ambroxol, venglustat) may address downstream aggregation, and LRRK2 inhibitors (DNL201, BIIB122) may reduce exosome release. The Skeptic revised confidence to 0.65; Domain Expert to 0.58, noting that alternative propagation mechanisms (tunneling nanotubes) may compensate for exosome blockade.
Curated pathway from expert analysis
flowchart TD
A["RAB27A GTPase<br/>Vesicle Trafficking"]
B["Synaptic Vesicle<br/>Exocytosis"]
C["Neurotransmitter<br/>Release"]
D["Cytoskeletal<br/>Remodeling"]
E["Dense Core Vesicle<br/>Secretion"]
F["Neuronal<br/>Communication"]
G["RAB27A Mutations<br/>Neurodevelopmental Disease"]
A --> B
B --> C
B --> D
C --> F
D --> F
A --> E
E --> F
G --> A
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style G fill:#6a1b9a,stroke:#ce93d8,color:#ce93d8No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for RAB27A yet. Search RCSB →
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for RAB27A.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
No resource usage or linked notebooks recorded for this hypothesis yet.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF patients with newly diagnosed Parkinson's disease (diagnosed <1 year) are stratified by baseline plasma exosome-associated α-synuclein concentration (high vs. low tertiles) AND followed longitudina | Mean MDS-UPDRS Part III score increase ≥8 points in high tertile vs. ≤4 points in low tertile at 36 months | — no observation — | pending | 0.48 |
| IF RAB27A expression is reduced by ≥70% in human iPSC-derived neurons (via CRISPRi or siRNA) AND these neurons are cocultured with α-synuclein preformed fibril (PFF)-seeded donor neurons for 14 days T | ≥50% reduction in recipient neuron phospho-α-synuclein (Ser129) aggregates relative to scramble control, measured by high-content imaging or ELISA | — no observation — | pending | 0.52 |